Cargando…
Reverse translation of phase I biomarker findings links the activity of angiotensin-(1–7) to repression of hypoxia inducible factor-1α in vascular sarcomas
BACKGROUND: In a phase I study of angiotensin-(1–7) [Ang-(1–7)], clinical benefit was associated with reduction in plasma placental growth factor (PlGF) concentrations. The current study examines Ang-(1–7) induced changes in biomarkers according to cancer type and investigates mechanisms of action e...
Autores principales: | Petty, W Jeffrey, Aklilu, Mebea, Varela, Victor A, Lovato, James, Savage, Paul D, Miller, Antonius A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495013/ https://www.ncbi.nlm.nih.gov/pubmed/22963500 http://dx.doi.org/10.1186/1471-2407-12-404 |
Ejemplares similares
-
Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma
por: Savage, Paul D., et al.
Publicado: (2016) -
Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer
por: BODDU, Prajwal, et al.
Publicado: (2016) -
Musashi mediates translational repression of the Drosophila hypoxia inducible factor
por: Bertolin, Agustina P., et al.
Publicado: (2016) -
Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes
por: Vasam, Goutham, et al.
Publicado: (2017) -
Reversal of Hypoxic Pulmonary Hypertension by Hypoxia-Inducible Overexpression of Angiotensin-(1-7) in Pulmonary Endothelial Cells
por: Liu, Man-Ling, et al.
Publicado: (2020)